- Home
- SSM vs BFRI Comparison
SSM vs BFRI Comparison
Compare SSM & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSM
- BFRI
- Stock Information
- Founded
- SSM N/A
- BFRI 1997
- Country
- SSM Germany
- BFRI United States
- Employees
- SSM 43
- BFRI N/A
- Industry
- SSM
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- SSM
- BFRI Health Care
- Exchange
- SSM Nasdaq
- BFRI Nasdaq
- Market Cap
- SSM 9.9M
- BFRI 11.1M
- IPO Year
- SSM N/A
- BFRI 2021
- Fundamental
- Price
- SSM $6.64
- BFRI $0.76
- Analyst Decision
- SSM
- BFRI Strong Buy
- Analyst Count
- SSM 0
- BFRI 1
- Target Price
- SSM N/A
- BFRI $2.75
- AVG Volume (30 Days)
- SSM N/A
- BFRI 199.4K
- Earning Date
- SSM N/A
- BFRI 11-12-2025
- Dividend Yield
- SSM N/A
- BFRI N/A
- EPS Growth
- SSM N/A
- BFRI N/A
- EPS
- SSM N/A
- BFRI N/A
- Revenue
- SSM N/A
- BFRI $37,164,000.00
- Revenue This Year
- SSM N/A
- BFRI $9.70
- Revenue Next Year
- SSM N/A
- BFRI $12.58
- P/E Ratio
- SSM N/A
- BFRI N/A
- Revenue Growth
- SSM N/A
- BFRI 5.11
- 52 Week Low
- SSM N/A
- BFRI $0.54
- 52 Week High
- SSM N/A
- BFRI $1.87
- Technical
- Relative Strength Index (RSI)
- SSM N/A
- BFRI 38.60
- Support Level
- SSM N/A
- BFRI $0.71
- Resistance Level
- SSM N/A
- BFRI $0.90
- Average True Range (ATR)
- SSM 0.00
- BFRI 0.10
- MACD
- SSM 0.00
- BFRI -0.03
- Stochastic Oscillator
- SSM 0.00
- BFRI 20.99
About SSM Sono Group N.V. Ordinary Shares
Sono Group NV is engaged in the field of solar-powered electric mobility. With its proprietary solar technology, the company is able to integrate solar panels into a vehicle's bodywork, using energy captured from the sun to charge the vehicle's battery. The group is engaged in the design and development of its own first solar electric vehicle, the Sion. Its Products and Services includes Complete Solar Solutions, Solar Charge Controllers, Solar Modules, and Data Services and Engineering Services.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.